
Brandon Bowers
Examiner (ID: 18540, Phone: (571)272-1888 , Office: P/2851 )
| Most Active Art Unit | 2851 |
| Art Unit(s) | 2825, 2851 |
| Total Applications | 890 |
| Issued Applications | 748 |
| Pending Applications | 52 |
| Abandoned Applications | 107 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13194123
[patent_doc_number] => 10111965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Cell penetrating peptides for intracellular delivery of molecules
[patent_app_type] => utility
[patent_app_number] => 15/428864
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 9352
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428864
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428864 | Cell penetrating peptides for intracellular delivery of molecules | Feb 8, 2017 | Issued |
Array
(
[id] => 12997425
[patent_doc_number] => 10022358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Methods for improving muscle and heart function
[patent_app_type] => utility
[patent_app_number] => 15/424311
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 9831
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424311 | Methods for improving muscle and heart function | Feb 2, 2017 | Issued |
Array
(
[id] => 13898993
[patent_doc_number] => 20190038701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => METHODS FOR DISRUPTING BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 16/074985
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074985 | Methods for disrupting biofilms | Feb 1, 2017 | Issued |
Array
(
[id] => 12029545
[patent_doc_number] => 20170319644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'MANUFACTURE OF DEGARELIX'
[patent_app_type] => utility
[patent_app_number] => 15/420156
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8336
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15420156
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/420156 | Manufacture of Degarelix | Jan 30, 2017 | Issued |
Array
(
[id] => 13823993
[patent_doc_number] => 20190015481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => CNP PRODRUGS WITH LARGE CARRIER MOIETIES
[patent_app_type] => utility
[patent_app_number] => 16/067057
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067057 | CNP prodrugs with large carrier moieties | Jan 4, 2017 | Issued |
Array
(
[id] => 11935205
[patent_doc_number] => 20170239355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/393143
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 57322
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393143
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393143 | USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS | Dec 27, 2016 | Abandoned |
Array
(
[id] => 11555194
[patent_doc_number] => 20170101441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'CHEMICAL AND BIOCHEMICAL ADDUCTS AS BIOMARKERS FOR ORGANOPHOSPHATE EXPOSURE'
[patent_app_type] => utility
[patent_app_number] => 15/391614
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17015
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/391614 | Chemical and biochemical adducts as biomarkers for organophosphate exposure | Dec 26, 2016 | Issued |
Array
(
[id] => 16413233
[patent_doc_number] => 10821094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Compositions and methods for treating allergic inflammatory conditions
[patent_app_type] => utility
[patent_app_number] => 16/069412
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 36
[patent_no_of_words] => 13623
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069412
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069412 | Compositions and methods for treating allergic inflammatory conditions | Dec 21, 2016 | Issued |
Array
(
[id] => 12837388
[patent_doc_number] => 20180170969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISEASES BY INHIBITING EXOSOME RELEASE
[patent_app_type] => utility
[patent_app_number] => 15/383454
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383454 | Compositions and methods for treating diseases by inhibiting exosome release | Dec 18, 2016 | Issued |
Array
(
[id] => 12105240
[patent_doc_number] => 09861707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'Treating bladder tumor cells using fibronectin attachment protein as a target'
[patent_app_type] => utility
[patent_app_number] => 15/376459
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 10246
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15376459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/376459 | Treating bladder tumor cells using fibronectin attachment protein as a target | Dec 11, 2016 | Issued |
Array
(
[id] => 16328373
[patent_doc_number] => 20200299339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => PROTEINACEOUS MOLECULES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/061074
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061074 | Proteinaceous molecules and methods of use | Dec 8, 2016 | Issued |
Array
(
[id] => 12786346
[patent_doc_number] => 20180153951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/369741
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/369741 | Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction | Dec 4, 2016 | Abandoned |
Array
(
[id] => 15666491
[patent_doc_number] => 10597466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Circular tandem repeat proteins
[patent_app_type] => utility
[patent_app_number] => 15/780397
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 85
[patent_no_of_words] => 17429
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780397
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780397 | Circular tandem repeat proteins | Dec 1, 2016 | Issued |
Array
(
[id] => 11499187
[patent_doc_number] => 20170073370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'BROAD SPECTRUM ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 15/358100
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 70129
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358100 | Broad spectrum antibiotics | Nov 20, 2016 | Issued |
Array
(
[id] => 12526953
[patent_doc_number] => 10005827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Double-acylated GLP-1 derivatives
[patent_app_type] => utility
[patent_app_number] => 15/346323
[patent_app_country] => US
[patent_app_date] => 2016-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37847
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15346323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/346323 | Double-acylated GLP-1 derivatives | Nov 7, 2016 | Issued |
Array
(
[id] => 11441876
[patent_doc_number] => 20170042898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/335776
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 36460
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335776 | METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS | Oct 26, 2016 | Abandoned |
Array
(
[id] => 11864650
[patent_doc_number] => 20170231935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH'
[patent_app_type] => utility
[patent_app_number] => 15/335242
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5785
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335242
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335242 | Administration of serine protease inhibitors to the stomach | Oct 25, 2016 | Issued |
Array
(
[id] => 12246260
[patent_doc_number] => 09919025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Pharmaceutical formulations of desmopressin'
[patent_app_type] => utility
[patent_app_number] => 15/333503
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9437
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15333503
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/333503 | Pharmaceutical formulations of desmopressin | Oct 24, 2016 | Issued |
Array
(
[id] => 13222797
[patent_doc_number] => 10125163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Solid phase peptide synthesis
[patent_app_type] => utility
[patent_app_number] => 15/299931
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5609
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299931 | Solid phase peptide synthesis | Oct 20, 2016 | Issued |
Array
(
[id] => 12259315
[patent_doc_number] => 20180078511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'SEQUENTIALLY DECOMPOSABLE POLYPEPTIDE-BASED NANOCARRIERS WITH PROTECTIVE SHELL AND PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/331460
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331460
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331460 | Sequentially decomposable polypeptide-based nanocarriers with protective shell and preparation thereof | Oct 20, 2016 | Issued |